Cart is empty A preclinical study evaluating a Kiwi-made COVID-19 vaccine—Kiwi Vax—has shown its unique formulation induces a safe and highly effective immune response to SARS-CoV-2 variants of concern, making it a promising booster vaccine candidate.
A preclinical study evaluating a Kiwi-made COVID-19 vaccine—Kiwi Vax—has shown its unique formulation induces a safe and highly effective immune response to SARS-CoV-2 variants of concern, making it a promising booster vaccine candidate.
Leave A Comment